Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-19-002313

Chief Technology Officer sold 3,000 shares at $20.42 ($61,260)

  • Chief Technology Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Myer Vickesh · Chief Technology Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-20 Exercise or conversion : show line 1 in the form +3,000 $0.65 $1,950 3,000 D
2019-02-20 Sale : show line 2 in the form −3,000 $20.42 $61,260 0 D
Open-market sales · 3,000 sh · avg $20.42 · $61,260

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-20 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −3,000 76,307 D
Loading xslF345X03/edgar.xml…